Skip to main content
. 2020 Feb 19;2(2):203–209. doi: 10.1016/j.jaccas.2019.11.076

Figure 5.

Figure 5

Serial Electrograms

Electrocardiograms demonstrating diffuse ST-segment changes 1 month following rechallenge with single-agent nivolumab (A) with subsequent partial normalization 1 month later (B).